All Industries

Top Life Sciences Companies

417 Life Sciences companies, sorted by total funding raised.

Maze

Maze is a user research platform that enables product teams to rapidly collect and share actionab...

San Francisco, United States51–200Life Sciences, Product Development
Series B·$57.5M·Jun 2022
S
Somite

Somite (now Cellular Intelligence) is an AI-native TechBio company building a universal virtual c...

Boston, Israel1–10Artificial Intelligence, Biotech
Series A·$57.1M·May 2025
Casana

Makes a smart toilet seat for in-home heart-health monitoring, providing effortless vital-sign co...

Rochester, United States11–50Life Sciences, Hardware
Series B·$56.2M·Jan 2022
InStride Health

Virtual pediatric provider delivering evidence-based anxiety and OCD treatment for children, teen...

Boston, United States51–200Life Sciences, Healthcare
Series B·$56.0M·Mar 2024
Cartwheel Care

Cartwheel is the trusted mental health partner to schools, delivering telehealth services and evi...

Cambridge, United States201–500Life Sciences, Healthcare
Grant·$55.2M·Oct 2025
Gennao Bio

Genetic medicines company developing targeted nucleic acid therapeutics using antibody-drug conju...

United States1–10Biotech, Life Sciences
Venture Round·$55.0M·Nov 2022
KG Bio

KGBio is a clinical-stage biotech company focused on the in-licensing, clinical development, and ...

Jakarta, IndonesiaLife Sciences
Series C·$55.0M·Jan 2021
RipplAcquired

Provides specialized dementia and elder mental health care, delivering 24/7 care navigation and c...

Seattle, United States51–200Life Sciences, Digital Health
Series A·$55.0M·Oct 2024
Lepure Biotech

LePure is a provider of single-use bioprocess solutions for biopharmaceutical companies in China.

Shanghai, China501–1000Life Sciences
Series C·$54.0M·Jan 2023
Rubedo Life Sciences

Clinical-stage biopharma developing therapies that target senescent/pathologic cells to treat age...

Sunnyvale, United States11–50Biotech, Drug Discovery
Series A·$52.0M·Apr 2024
Manas AI

AI-native biopharmaceutical company using neuro-symbolic models to accelerate drug discovery for ...

New York, United States1–10Life Sciences, Artificial Intelligence
Extension Round·$50.6M·Sep 2025
Allonnia

Allonnia engineers breakthrough systems to develop and commercialize new waste remediation and ma...

Boston, United States11–50Life Sciences, Biotech
Extension Round·$50.0M·Dec 2025
CB
Chengyuan Bio (呈源生物)

Life sciences portfolio company

China11–50Biotech, Life Sciences
Series B·$50.0M·Sep 2021
Circulo

Medicaid-focused insurtech building tech-enabled Medicaid managed care plans and services for hig...

Columbus, United States51–200Life Sciences, Healthcare
Series A·$50.0M·Feb 2021
Nicoya Lifesciences

Biotech company making nanotechnology-based biosensors and SPR instruments for biomolecular inter...

Kitchener, Canada51–200Life Sciences, Biotech
Series A·$50.0M·Dec 2021
Radial

Operates a network of clinics delivering advanced, fast-acting mental health treatments (TMS, Spr...

New York, United States11–50Life Sciences, Healthcare
Series A·$50.0M·Dec 2025
Xellar Biosystems

Biotech company building 3D bio intelligence infrastructure including organ-on-chip systems for d...

Boston, United States11–50Biotech, Life Sciences
Series A·$50.0M·Jun 2026
DashBio

AI and robotics enabled drug development, starting with clinical bioanalysis.

Boston, United States11–50Biotech, Life Sciences
Series A·$47.5M·Aug 2026
Moleculent AB

Life science platform enabling researchers to detect cell-cell interactions and study cellular co...

Solna, Sweden11–50Biotech, Life Sciences
Series B·$46.0M·Apr 2026
Spear Bio

Develops ultra-sensitive homogeneous immunoassay kits and services for biomarker research and cli...

Boston, United States11–50Biotech, Diagnostics
Series A·$45.0M·Jul 2024
August Health

AI-enabled EHR and operations platform for senior living communities.

San Francisco, United States51–200Life Sciences, Healthcare
Series B·$44.0M·Aug 2025
BrighterAcquired

Dental marketplace and digital benefits platform connecting patients, dentists, and insurers to i...

Santa Monica, United States51–200Life Sciences, Healthcare
Series D·$44.0M·Apr 2016
Glyphic Biotechnologies

Developing a single-molecule, high-throughput proteome sequencing platform (ProSE) for researcher...

Berkeley, United States11–50Biotech, Genomics
Series A·$42.5M·Sep 2025
Tahoe Therapeutics

AI-powered biotechnology company building virtual cell models and gigascale single-cell datasets ...

South San Francisco, United States11–50Life Sciences, Artificial Intelligence
Venture Round·$42.0M·Aug 2025
Plume Health

Virtual gender-affirming clinic delivering telehealth hormone therapy, mental-health care, and co...

Colorado, United States51–200Life Sciences, Healthcare
Series B·$40.9M·Aug 2022